We are live on ! Find out more
CL icon

Colgate-Palmolive

1,820 hedge funds and large institutions have $65B invested in Colgate-Palmolive in 2024 Q2 according to their latest regulatory filings, with 159 funds opening new positions, 620 increasing their positions, 668 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more first-time investments, than exits

New positions opened: 159 | Existing positions closed: 79

15% more call options, than puts

Call options by funds: $456M | Put options by funds: $398M

11% more funds holding in top 10

Funds holding in top 10: 910 (+1)

7% more capital invested

Capital invested by funds: $60.7B → $65B (+$4.29B)

3% more funds holding

Funds holding: 1,7661,820 (+54)

0.33% less ownership

Funds ownership: 82.06%81.73% (-0.33%)

7% less repeat investments, than reductions

Existing positions increased: 620 | Existing positions reduced: 668

Holders
1,820
Holders Change
+54
Holders Change %
+3.06%
% of All Funds
26.28%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.14%
New
159
Increased
620
Reduced
668
Closed
79
Calls
$456M
Puts
$398M
Net Calls
+$58.1M
Net Calls Change
-$679M
Name Holding Trade Value Shares
Change
Change in
Stake
RFC
351
Regions Financial Corp
Alabama
$8.57M -$303K -3,288 -4%
GIBU
352
Gulf International Bank (UK)
United Kingdom
$8.48M +$32.9K +357 +0.4%
PA
353
Pinnacle Associates
New York
$8.19M -$60K -650 -0.8%
BL
354
BFSG LLC
California
$8.16M -$92K -997 -1%
RCYC
355
Richard C. Young & Co
Rhode Island
$8.14M +$408K +4,421 +6%
WA
356
Waverly Advisors
Alabama
$8.09M +$6.99M +75,818 +1,008%
PC
357
Port Capital
Illinois
$8.07M -$3.14K -34 -0%
GAM
358
Gotham Asset Management
New York
$7.97M -$845K -9,163 -10%
WDA
359
Wendell David Associates
New Hampshire
$7.94M +$25.3K +274 +0.3%
Verition Fund Management
360
Verition Fund Management
Connecticut
$7.94M +$493K +5,347 +7%
DT
361
Diversified Trust
Tennessee
$7.9M +$69.8K +757 +0.9%
CCT
362
Chemung Canal Trust
New York
$7.89M -$676K -7,329 -8%
WBC
363
Westpac Banking Corp
Australia
$7.89M -$11.4M -124,069 -60%
Jacobs Levy Equity Management
364
Jacobs Levy Equity Management
New Jersey
$7.83M +$7.44M +80,686 New
UCFA
365
United Capital Financial Advisors
Texas
$7.83M -$56.8K -616 -0.8%
MGP
366
M&G plc
United Kingdom
$7.76M +$3.47M +37,616 +89%
AI
367
Atria Investments
North Carolina
$7.74M +$1.12M +12,177 +18%
SIC
368
Salem Investment Counselors
North Carolina
$7.74M +$84.7K +918 +1%
VIM
369
Vinva Investment Management
Australia
$7.55M +$1.43M +15,450 +25%
ABC
370
Associated Banc-Corp
Wisconsin
$7.51M -$246K -2,666 -3%
JIC
371
Johnson Investment Counsel
Ohio
$7.49M -$652K -7,063 -8%
KCM
372
Kanawha Capital Management
Virginia
$7.47M +$42.9K +465 +0.6%
FDCDDQ
373
Federation des caisses Desjardins du Quebec
Quebec, Canada
$7.42M +$2.93M +31,720 +71%
CF
374
Canoe Financial
Alberta, Canada
$7.39M
VPIM
375
Vanguard Personalized Indexing Management
California
$7.32M +$1.37M +14,811 +24%

CL Hedge Fund Activity: Q2 2024 in Review

1,820 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Colgate-Palmolive (CL) for Q2 2024, worth a combined $65B — up 7.1% from $60.7B a quarter earlier.

Buyers outnumbered sellers: 159 funds opened new CL positions and 79 closed out — a net gain of 80 holders — while 620 added to existing stakes and 668 trimmed.

The largest buyer was GQG Partners, opening a new position worth an estimated $780M. The largest seller was Wellington Management Group, cutting an estimated $1.04B.

  • 1,820 institutional investors held Colgate-Palmolive (CL) as of Q2 2024, up from 1,766 in Q1 2024.
  • Funds reported $65B of Colgate-Palmolive stock for Q2 2024, up 7.1% quarter-over-quarter.
  • 159 funds opened new Colgate-Palmolive positions in Q2 2024 and 79 closed out, a net change of +80 holders.
  • The largest Colgate-Palmolive buyer in Q2 2024 was GQG Partners, an estimated $780M added.
  • The largest Colgate-Palmolive seller in Q2 2024 was Wellington Management Group, an estimated $1.04B sold.

Based on aggregated 13F filings for Q2 2024.